Adjunctive treatment and BoNT-A for post-stroke spasticity: Are we really focusing on the patient-centered goals?

COPYRIGHT © 2023 Baricich, Bertoni, Santamato, Osio, Gasperini, Picelli, Molteni and The Collaborative Working Group. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. Adjunctive treatment and BoNT-A for post-stroke spasticity: Are we really focusing on the patient-centered goals?

[1]  F. Molteni,et al.  BoNT-A for Post-Stroke Spasticity: Guidance on Unmet Clinical Needs from a Delphi Panel Approach , 2021, Toxins.

[2]  H. Hefter,et al.  Long‐term adherence and response to botulinum toxin in different indications , 2020, Annals of clinical and translational neurology.

[3]  S. Ghroubi,et al.  Efficacy of botulinum toxin A for the treatment of hemiparesis in adults with chronic upper limb spasticity , 2020, The Pan African medical journal.

[4]  N. Yamada,et al.  Botulinum Toxin Therapy Combined with Rehabilitation for Stroke: A Systematic Review of Effect on Motor Function , 2019, Toxins.

[5]  J. Valls-Solé,et al.  Botulinum Toxin Type A Improves Function According to Goal Attainment in Adults with Poststroke Lower Limb Spasticity in Real Life Practice , 2019, European Neurology.

[6]  G. Wittenberg,et al.  OnabotulinumtoxinA Treatment in Adults with Spasticity Reduces Caregiver Burden: Results from the ASPIRE Study , 2019, Archives of Physical Medicine and Rehabilitation.

[7]  G. Kwakkel,et al.  Effectiveness of Botulinum Toxin Treatment for Upper Limb Spasticity Poststroke Over Different ICF Domains: a Systematic Review and Meta-Analysis. , 2019, Archives of physical medicine and rehabilitation.

[8]  N. Smania,et al.  Adjuvant treatments associated with botulinum toxin injection for managing spasticity: An overview of the literature. , 2019, Annals of physical and rehabilitation medicine.

[9]  Ying Chen,et al.  Efficacy and Safety of Botulinum Toxin Type A for Limb Spasticity after Stroke: A Meta-Analysis of Randomized Controlled Trials , 2019, BioMed research international.

[10]  Pengfei Guo,et al.  A meta-analysis of randomized controlled trials , 2019, Medicine.

[11]  A. Esquenazi,et al.  OnabotulinumtoxinA for the Treatment of Poststroke Distal Lower Limb Spasticity: A Randomized Trial. , 2018, PM & R : the journal of injury, function, and rehabilitation.

[12]  L. Turner-Stokes,et al.  Relief of spasticity-related pain with botulinum neurotoxin-A (bont-A) in real life practice. Post-hoc analysis from a large international cohort series , 2018, Annals of Physical and Rehabilitation Medicine.

[13]  Gavin Williams,et al.  Therapy influences goal attainment following botulinum neurotoxin injection for focal spasticity in adults with neurological conditions , 2018, Brain injury.

[14]  A. Esquenazi,et al.  Efficacy and safety of abobotulinumtoxinA in spastic lower limb , 2017, Neurology.

[15]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[16]  N. Smania,et al.  The Italian real-life post-stroke spasticity survey: unmet needs in the management of spasticity with botulinum toxin type A. , 2017, Functional neurology.

[17]  M. Sudoł,et al.  Systematic review of adjunct therapies to improve outcomes following botulinum toxin injection for treatment of limb spasticity , 2016, Clinical rehabilitation.

[18]  C. Kilbride,et al.  Incidence, Time Course and Predictors of Impairments Relating to Caring for the Profoundly Affected arm After Stroke: A Systematic Review , 2015, Physiotherapy research international : the journal for researchers and clinicians in physical therapy.

[19]  Sheng Li,et al.  New insights into the pathophysiology of post-stroke spasticity , 2015, Front. Hum. Neurosci..

[20]  L. Anderson,et al.  Clinical Understanding of Spasticity: Implications for Practice , 2014, Rehabilitation research and practice.

[21]  N. Lannin,et al.  Rehabilitation Therapies After Botulinum Toxin-A Injection to Manage Limb Spasticity: A Systematic Review , 2014, Physical Therapy.

[22]  G. Kwakkel,et al.  What Is the Evidence for Physical Therapy Poststroke? A Systematic Review and Meta-Analysis , 2014, PloS one.

[23]  D. Moher,et al.  Developing a guideline for clinical trial protocol content: Delphi consensus survey , 2012, Trials.

[24]  G. Rubin,et al.  Development of a community-based model for respiratory care services , 2012, BMC Health Services Research.

[25]  D. Guehl,et al.  Safety and self-reported efficacy of botulinum toxin for adult spasticity in current clinical practice: a prospective observational study , 2012, Clinical rehabilitation.

[26]  Y. Dundar,et al.  Overview of the literature , 2012 .

[27]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[28]  P. Langhorne,et al.  Stroke rehabilitation , 2011, The Lancet.

[29]  A. Esquenazi,et al.  Effects of Botulinum Toxin-A on Gait Velocity, Step Length, and Base of Support of Patients with Dynamic Equinovarus Foot , 2006, American journal of physical medicine & rehabilitation.

[30]  J. Marsden,et al.  Clinical management of spasticity , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[31]  Suzanne D. Pawlowski,et al.  The Delphi method as a research tool: an example, design considerations and applications , 2004, Inf. Manag..

[32]  F. Panza,et al.  Botulinum Toxin Type A for the Treatment of Lower Limb Spasticity after Stroke , 2018, Drugs.

[33]  Marta Elena Losa-Iglesias,et al.  Footwear used by older people and a history of hyperkeratotic lesions on the foot , 2017, Medicine.

[34]  Hsin-Chieh Yeh,et al.  Effect of the 2011 vs 2003 duty hour regulation-compliant models on sleep duration, trainee education, and continuity of patient care among internal medicine house staff: a randomized trial. , 2013, JAMA internal medicine.

[35]  B. Bhakta,et al.  Associated reactions after stroke: a randomized controlled trial of the effect of botulinum toxin type A. , 2008, Journal of rehabilitation medicine.

[36]  R. Iedema,et al.  Implications for practice , 2008 .